Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2008, Vol. 28 Issue (3): 106-111    DOI:
    
Strategys of Recombinant Construction and High Expression for Antihypertensive Peptides
WANG Xiao Li
华南理工大学生物科学与工程学院
Download: HTML   PDF(432KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Antihypertensive peptides (AHPs) have good effect of decreasing blood pressure, also have low adverse effects and toxicity. Now it has been received great interests in gene engineering. This paper briefly reviewed the necessity of construction gene-engineering strain which expressing AHPs and other small peptides. Discussed the strategys and theoretical foundation of chosen peptides, construction tandem repeats, chosen expression vectors during the gene engineering constructions, mainly introduced the advantages and disadvantages of different types of expressing vectors. The purpose of this paper is to providing a reference for the future construction gene-engineering strain which expressing AHPs and conveniencing the design of this kind of experiment.



Key wordsAntihypertensive peptides      Gene engineering      Construction      Expression     
Received: 10 December 2007      Published: 28 March 2008
Cite this article:

WANG Xiao Li . Strategys of Recombinant Construction and High Expression for Antihypertensive Peptides. China Biotechnology, 2008, 28(3): 106-111.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2008/V28/I3/106

[1] QIAO Sheng-tai,WANG Man-qi,XU Hui-ni. Functional Analysis of Prokaryotic Expression Protein of Tomato SlTpx in Vitro[J]. China Biotechnology, 2021, 41(8): 25-32.
[2] LI Bing,ZHANG Chuan-bo,SONG Kai,LU Wen-yu. Research Progress in Biosynthesis of Rare Ginsenosides[J]. China Biotechnology, 2021, 41(6): 71-88.
[3] WANG Hui-lin,ZHOU Kai-qiang,ZHU Hong-yu,WANG Li-jing,YANG Zhong-fan,XU Ming-bo,CAO Rong-yue. Research Progress of Human Coagulation Factor VII and the Recombinant Expression Systems[J]. China Biotechnology, 2021, 41(2/3): 129-137.
[4] ZHANG Lei,TANG Yong-kai,LI Hong-xia,LI Jian-lin,XU Yu-xin,LI Ying-bin,YU Ju-hua. Advances in Promoting Solubility of Prokaryotic Expressed Proteins[J]. China Biotechnology, 2021, 41(2/3): 138-149.
[5] LIU Mei-qin,GAO Bo,JIAO Yue-ying,LI Wei,YU Jie-mei,PENG Xiang-lei,ZHENG Yan-peng,FU Yuan-hui,HE Jin-sheng. Long Non-coding RNA Expression Profile in A549 Cells Infected with Human Respiratory Syncytial Virus[J]. China Biotechnology, 2021, 41(2/3): 7-13.
[6] YANG Xi,LUAN Yu-shi. Preliminary Study of Sly-miR399 in Tomato Resistance to Late Blight[J]. China Biotechnology, 2021, 41(11): 23-31.
[7] WU Han-rong,WANG Ying,LI Su-ning,SANG Xiao-dong,FAN Ling. Policy Research on the Construction of Biotechnology Base Platforms in China[J]. China Biotechnology, 2021, 41(10): 127-131.
[8] CHEN Su-fang,XIA Ming-yin,ZENG Li-yan,AN Xiao-qin,TIAN Min-fang,PENG Jian. Recombinant Expression and Detection of Antimicrobial Activity of Cec4a[J]. China Biotechnology, 2021, 41(10): 12-18.
[9] SHI Peng-cheng, JI Xiao-jun. Advances in Expression of Human Epidermal Growth Factor in Yeast[J]. China Biotechnology, 2021, 41(1): 72-79.
[10] RAO Hai-mi,LIANG Dong-mei,LI Wei-guo,QIAO Jian-jun,CAI YIN Qing-ge-le. Advances in Synthetic Biology of Fungal Aromatic Polyketides[J]. China Biotechnology, 2020, 40(9): 52-61.
[11] DENG Tong,ZHOU Hai-sheng,WU Jian-ping,YANG Li-rong. Enhance Soluble Heteroexpression of a NADPH-Dependent Alcohol Dehydrogenase Based on the Chaperone Strategy[J]. China Biotechnology, 2020, 40(8): 24-32.
[12] ZHANG Xiao-hang,LI Yuan-yuan,JIA Min-xuan,GU Qi. Identification and Expression of Elastin-like Polypeptides[J]. China Biotechnology, 2020, 40(8): 33-40.
[13] LV Yi-fan,LI Geng-dong,XUE Nan,LV Guo-liang,SHI Shao-hui,WANG Chun-sheng. Prokaryotic Expression, Purification of LbCpf1 Protein Gene and in Vitro Cleavage Activity Assay[J]. China Biotechnology, 2020, 40(8): 41-48.
[14] PENG Xiang-lei,WANG Ye,WANG Li-nan,SU Yan-bin,FU Yuan-hui,ZHENG Yan-peng,HE Jin-sheng. Single-Primer PCR for Site-Directed Mutagenesis[J]. China Biotechnology, 2020, 40(8): 19-23.
[15] JIANG Dan-dan,WANG Yun-long,LI Yu-lin,Zhang Yi-qing. Study on the Delivery of RGD Modified Virus-Like Particles to ICG Targeted Tumors[J]. China Biotechnology, 2020, 40(7): 22-29.